S. Pippig

发表

Mechanism of inhibition of Raf-1 by protein kinase A

W. Kolch, P. Janosch, M. Ueffing, 1994, Molecular and cellular biology.

Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Goettingen miniature pig comparing autogenous bone and rhGDF-5.

H. Schliephake, S. Pippig, A. Ludwig, 2009, Clinical oral implants research.

In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells

R. Eckert, S. Pippig, P. Fielder, 2004, Journal of Pharmacology and Experimental Therapeutics.

Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibody.

S. Pippig, Benjamin Wu, A. Joshi, 2004, Regulatory toxicology and pharmacology : RTP.

TISSUE DISTRIBUTION AND RECEPTOR-MEDIATED CLEARANCE OF ANTI-CD11A ANTIBODY IN MICE

S. Pippig, B. Reitz, J. Fox, 2005, Drug Metabolism and Disposition.

Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors.

M. Caron, R. Lefkowitz, M. Lohse, 1993, The Journal of biological chemistry.

The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion1

M. Croft, N. Killeen, S. Pippig, 2000, The Journal of Immunology.

Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).

R. Locksley, A. Barclay, N. Killeen, 1999, Journal of immunology.

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein

J. Buchner, S. Pippig, U. Protzer, 2021, Antiviral Research.

IL-6 and MCP-1 production monocytes by soluble factors synergistically enhances Interaction of vascular smooth muscle cells and

S. Rose-John, K. Werdan, S. Koch, 2016 .

Signaling checkpoints during the development of T lymphocytes.

N. Killeen, S. Pippig, B. Irving, 1998, Current opinion in immunology.

Biosimilar Monoclonal Antibodies

S. Pippig, R. Zoubek, C. Brockmeyer, 2014 .

Tissue Distribution and Receptor-Mediated Clearance of anti-CD 11 a Antibody in Mice

S. Pippig, B. Reitz, J. Fox, 2005 .

Phosducin is a protein kinase A-regulated G-protein regulator

B. Obermaier, M. Lohse, S. Pippig, 1992, Nature.

Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs.

S. Pippig, Seong-Ho Choi, U. Wikesjö, 2010, Journal of clinical periodontology.

Evaluation of an injectable rhGDF-5/PLGA construct for minimally invasive periodontal regenerative procedures: a histological study in the dog.

S. Pippig, C. Susin, U. Wikesjö, 2010, Journal of clinical periodontology.

Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization.

M. Lohse, S. Pippig, M J Lohse, 1995, Molecular pharmacology.

Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production.

Karl Werdan, Stefan Rose-John, S. Rose-John, 2009, American journal of physiology. Heart and circulatory physiology.

Efficient inhibition of SARS-CoV-2 strains by a novel ACE2-IgG4-Fc fusion protein with a stabilized hinge region

J. Buchner, S. Pippig, Chongguang Chen, 2020, bioRxiv.

Clinical relevance of urokinase‐type plasminogen activator and its inhibitor type 1 (PAI‐1) in squamous cell carcinoma of the uterine cervix

S. Pippig, B. Hentschel, G. Raptis, 2002, The Australian & New Zealand journal of obstetrics & gynaecology.

Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 (rhGDF-5) in an absorbable collagen sponge carrier into one-wall intrabony defects in dogs: a dose-range study.

S. Pippig, U. Wikesjö, M. Siedler, 2009, Journal of clinical periodontology.

Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs.

S. Pippig, Young-Taek Kim, U. Wikesjö, 2010, Journal of clinical periodontology.

Superior effect of MD05, beta-tricalcium phosphate coated with recombinant human growth/differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model.

S. Pippig, M. Siedler, S. Poehling, 2006, Journal of periodontology.

Wound healing/regeneration using recombinant human growth/differentiation factor-5 in an injectable poly-lactide-co-glycolide-acid composite carrier and a one-wall intra-bony defect model in dogs.

Chang-Sung Kim, Jung-Chul Park, S. Pippig, 2011, Journal of clinical periodontology.

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects

S. Pippig, A. Schlitt, M. Buerke, 2009, Vascular health and risk management.

Maturation of periodontal tissues following implantation of rhGDF-5/β-TCP in one-wall intra-bony defects in dogs: 24-week histological observations.

S. Pippig, Seong-Ho Choi, U. Wikesjö, 2012, Journal of clinical periodontology.

Development of an injectable composite as a carrier for growth factor-enhanced periodontal regeneration.

Andreas Schuetz, Michael Siedler, S. Pippig, 2008, Journal of clinical periodontology.

Maturation of alveolar bone following implantation of an rhGDF-5/PLGA composite into 1-wall intra-bony defects in dogs: 24-week histometric observations.

S. Pippig, U. Wikesjö, Ki‐Tae Koo, 2012, Journal of clinical periodontology.

The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs.

S. Pippig, M. Hürzeler, Otto Zuhr, 2009, The International journal of oral & maxillofacial implants.

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects

S. Pippig, A. Schlitt, M. Buerke, 2009, Vascular health and risk management.

The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion1

M. Croft, N. Killeen, S. Pippig, 2000, The Journal of Immunology.

Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production.

S. Rose-John, K. Werdan, S. Koch, 2009, American journal of physiology. Heart and circulatory physiology.